Non-breast SPC risks were lower for female BC survivors of Asian, Black, Chinese, or other non-White, non-mixed ethnicities compared to white ethnicity female BC survivors and for females whose first BC was ER-positive rather than ER-negative and HER2-positive rather than HER2-negative. This evidence concerns the gene ERBB2 and breast cancer.